WHO Adds REGEN-COV to List of Recommended COVID-19 Treatments
The World Health Organization (WHO) has added Regeneron’s COVID-19 antibody cocktail, REGEN-COV (casirivimab/imdevimab), to its list of recommended treatments in updated clinical guidelines.
The world body also announced that it is in negotiations with Roche, which is distributing the cocktail through a deal with Regeneron. The WHO also highlighted the “high cost and low availability of the combination therapy” as a barrier to access and said it is in discussions with Regeneron to donate REGEN-COV treatment courses.
In the U.S., REGEN-COV is authorized to prevent and treat COVID-19 infection in people aged 12 years and older who have been exposed to the coronavirus and are at high risk of progressing to severe disease.